Last reviewed · How we verify

NCT05103956

Hemostatic Patch/Collagen Sealant and Polyethylene Glycol (Hemopatch) in the Postoperative of the Thyroidectomy.

Status unknown Last updated 17 November 2021
What this trial tests

trial in Goiter in 108 participants. Status unknown.

Timeline
1 October 2021
Primary endpoint
1 April 2022
1 April 2022

Quick facts

Lead sponsorFundación Pública Andaluza para la gestión de la Investigación en Sevilla
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment108
Start date1 October 2021
Primary completion1 April 2022
Estimated completion1 April 2022
Sites1 location across Spain

Conditions studied

Sponsor

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla — full company profile →

Who can join

18 and older, any sex, with Goiter. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational study with non-inferiority, prospective, randomized (1: 1) and open-label medical device. The study has 2 treatment groups (HEMOPATCH® versus standard hemostasis).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Goiter

Currently open trials in the same condition.

Other Fundación Pública Andaluza para la gestión de la Investigación en Sevilla trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05103956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing